Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth W Mahaffey

Showing results (281-290 of 635) with videos related to

Pageof 64
Sort By:
Contemporary Clinical Trials|April 1, 2006
Comparing classifications of death in the Mode Selection Trial: agreement and disagreement among site investigators and a clinical events committeeJohn L Petersen, Ghazala Haque, Anne S Hellkamp, et al.
JACC. Clinical Electrophysiology|May 17, 2018
Rhythm Control Versus Rate Control and Clinical Outcomes in Patients With Atrial Fibrillation: Results From the ORBIT-AF RegistryAmit Noheria, Peter Shrader, Jonathan P Piccini, et al.
Clinical Journal of the American Society of Nephrology : CJASN|April 16, 2024
Effects of Sodium-Glucose Cotransporter 2 Inhibitors on Cause-Specific Cardiovascular Death in Patients with CKD: A Meta-Analysis of CKD Progression TrialsRobert A Fletcher, William G Herrington, Rajiv Agarwal, et al.
JACC. Cardiovascular Interventions|September 24, 2016
Efficacy and Safety of Cangrelor in Preventing Periprocedural Complications in Patients With Stable Angina and Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention: The CHAMPION PHOENIX TrialJérémie Abtan, P Gabriel Steg, Gregg W Stone, et al.
Cardiology|June 22, 2002
Grade III ischemia on presentation with acute myocardial infarction predicts rapid progression of necrosis and less myocardial salvage with thrombolysisYochai Birnbaum, Kenneth W Mahaffey, Douglas A Criger, et al.
The American Journal of Cardiology|February 19, 2004
Risk factors for intracranial hemorrhage and nonhemorrhagic stroke after fibrinolytic therapy (from the GUSTO-i trial)David E Kandzari, Christopher B Granger, Maarten L Simoons, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 18, 2023
The rationale, design and baseline data of FLOW, a kidney outcomes trial with once-weekly semaglutide in people with type 2 diabetes and chronic kidney diseasePeter Rossing, Florian M M Baeres, George Bakris, et al.
Journal of the American Heart Association|September 16, 2015
Increased Heart Rate Is Associated With Higher Mortality in Patients With Atrial Fibrillation (AF): Results From the Outcomes Registry for Better Informed Treatment of AF (ORBIT-AF)Benjamin A Steinberg, Sunghee Kim, Laine Thomas, et al.
Journal of the American College of Cardiology|February 21, 2006
A comparison of the clinical impact of bleeding measured by two different classifications among patients with acute coronary syndromesSunil V Rao, Kristi O'Grady, Karen S Pieper, et al.
The American Journal of Medicine|June 22, 2013
Use of evidence-based cardiac prevention therapy among outpatients with atrial fibrillationPaul L Hess, Sunghee Kim, Jonathan P Piccini, et al.
Pageof 64

Showing results (281-290 of 635) with videos related to

Sort By:
Pageof 64
Contemporary Clinical Trials|April 1, 2006
Comparing classifications of death in the Mode Selection Trial: agreement and disagreement among site investigators and a clinical events committeeJohn L Petersen, Ghazala Haque, Anne S Hellkamp, et al.
JACC. Clinical Electrophysiology|May 17, 2018
Rhythm Control Versus Rate Control and Clinical Outcomes in Patients With Atrial Fibrillation: Results From the ORBIT-AF RegistryAmit Noheria, Peter Shrader, Jonathan P Piccini, et al.
Clinical Journal of the American Society of Nephrology : CJASN|April 16, 2024
Effects of Sodium-Glucose Cotransporter 2 Inhibitors on Cause-Specific Cardiovascular Death in Patients with CKD: A Meta-Analysis of CKD Progression TrialsRobert A Fletcher, William G Herrington, Rajiv Agarwal, et al.
JACC. Cardiovascular Interventions|September 24, 2016
Efficacy and Safety of Cangrelor in Preventing Periprocedural Complications in Patients With Stable Angina and Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention: The CHAMPION PHOENIX TrialJérémie Abtan, P Gabriel Steg, Gregg W Stone, et al.
Cardiology|June 22, 2002
Grade III ischemia on presentation with acute myocardial infarction predicts rapid progression of necrosis and less myocardial salvage with thrombolysisYochai Birnbaum, Kenneth W Mahaffey, Douglas A Criger, et al.
The American Journal of Cardiology|February 19, 2004
Risk factors for intracranial hemorrhage and nonhemorrhagic stroke after fibrinolytic therapy (from the GUSTO-i trial)David E Kandzari, Christopher B Granger, Maarten L Simoons, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 18, 2023
The rationale, design and baseline data of FLOW, a kidney outcomes trial with once-weekly semaglutide in people with type 2 diabetes and chronic kidney diseasePeter Rossing, Florian M M Baeres, George Bakris, et al.
Journal of the American Heart Association|September 16, 2015
Increased Heart Rate Is Associated With Higher Mortality in Patients With Atrial Fibrillation (AF): Results From the Outcomes Registry for Better Informed Treatment of AF (ORBIT-AF)Benjamin A Steinberg, Sunghee Kim, Laine Thomas, et al.
Journal of the American College of Cardiology|February 21, 2006
A comparison of the clinical impact of bleeding measured by two different classifications among patients with acute coronary syndromesSunil V Rao, Kristi O'Grady, Karen S Pieper, et al.
The American Journal of Medicine|June 22, 2013
Use of evidence-based cardiac prevention therapy among outpatients with atrial fibrillationPaul L Hess, Sunghee Kim, Jonathan P Piccini, et al.
Pageof 64